FDAsafety guidance72% confidence
Clinical Outcome Assessments (COA) Qualification Program Submissions
Source: FDA
Why This Matters
Why this matters: illustrates how regulators handled a comparable safety guidance decision relevant to Metformin.
Regulatory Analysis
Supporting Context
- Therapeutic area
- Aging · Metformin
- Sub-indication
- General
Related signal: Metformin Aging Study to Assess Insulin Sensitivity and Mitochondrial Function